There’s an article in the Washington Post by the chief officer of the AAAS and editor of ‘Science’ which can be summed up here:
We simply cannot invest all our hopes in a single approach. Federal funding is essential for both adult and embryonic stem cell research, even as promising alternatives are beginning to emerge.
I’m glad to see the editor of the journal which published one of the skin cell-turn-stem cell papers speak out on this issue, and be perfectly clear that this in no way vindicates the Bush administration’s policy and vetos.